SCHEMBL19087508

SCHEMBL19087508

Cc1ccccc1Nc1ccc2c(c1)oc1ccccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 7/20 0.56
▸ ALDH1A1 P00352 7/20 0.56
▸ LMNA P02545 5/20 0.56
▸ MEN1 O00255 6/20 0.50
▸ KMT2A Q03164 6/20 0.50
▸ GAA P10253 5/20 0.50
▸ NPC1 O15118 5/20 0.50
▸ RAB9A P51151 5/20 0.50
▸ MAPT P10636 5/20 0.49
▸ HPGD P15428 5/20 0.49
▸ L3MBTL1 Q9Y468 2/20 0.49
▸ DUSP3 P51452 1/20 0.49
▸ KDM4E B2RXH2 4/20 0.48
▸ CYP1A2 P05177 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ HTT P42858 2/20 0.46
▸ HSD17B10 Q99714 2/20 0.45
▸ TP53 P04637 2/20 0.45
▸ AHR P35869 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30477869 0.87 LMNA (0.59) SMN1; SMN2ALDH1A1LMNAMEN1KMT2A
SCHEMBL23358311 0.87 LMNA (0.59) SMN1; SMN2ALDH1A1LMNAMEN1KMT2A
SCHEMBL19842088 0.85 ALDH1A1 (0.51) SMN1; SMN2ALDH1A1LMNAKMT2AGAA
SCHEMBL21226190 0.84 DUSP3 (0.52) SMN1; SMN2ALDH1A1LMNAMEN1KMT2A
SCHEMBL17283499 0.83 KMT2A (0.60) SMN1; SMN2ALDH1A1LMNAMEN1KMT2A
SCHEMBL19656443 0.83 DUSP3 (0.53) SMN1; SMN2ALDH1A1LMNAMEN1KMT2A
SCHEMBL21453125 0.83 LMNA (0.52) SMN1; SMN2ALDH1A1LMNAMEN1KMT2A
SCHEMBL21585381 0.81 KMT2A (0.49) SMN1; SMN2ALDH1A1LMNAMEN1KMT2A
SCHEMBL14295754 0.81 DUSP3 (0.67) SMN1; SMN2ALDH1A1LMNAMEN1KMT2A
SCHEMBL18685586 0.81 SMN1; SMN2 (0.52) SMN1; SMN2ALDH1A1LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113924307-B Polycyclic compound and organic light-emitting element including the same 株式会社LG化学 2024-08-20 — — CN disclosed
EP-4219497-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE Samsung Display Co., Ltd. (KR) 2023-08-02 — — EP disclosed
CN-116507146-A Heterocyclic compound, light-emitting device including the same, and electronic apparatus 三星显示有限公司 2023-07-28 — — CN disclosed
US-20230240135-A1 HETEROCYLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-27 — — US disclosed
US-20230240135-A1 HETEROCYLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-27 — — US disclosed
WO-2021107711-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME 주식회사 엘지화학 2021-06-03 — — WO disclosed
WO-2021107711-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME 주식회사 엘지화학 2021-06-03 — — WO disclosed
US-20190006592-A1 NOVEL ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME MATERIAL SCIENCE CO., LTD. (KR) 2019-01-03 — — US disclosed
US-20190006592-A1 NOVEL ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME MATERIAL SCIENCE CO., LTD. (KR) 2019-01-03 — — US disclosed
WO-2018128470-A1 ORGANIC ELECTROLUMINESCENT ELEMENT 머티어리얼사이언스 주식회사 2018-07-12 — — WO disclosed
WO-2017116169-A1 NOVEL ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME 머티어리얼사이언스 주식회사 2017-07-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190006592-A1 NOVEL ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME OCIAD1, OCIAD2, ORC3 SMN1; SMN2 4712/4885ALDH1A1 731/4885LMNA 2190/4885
US-20230240135-A1 HETEROCYLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE CRY1, LAGE3, NQO1 SMN1; SMN2 4146/4885ALDH1A1 22/4885LMNA 1479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback